
Formation Bio is a tech-driven, AI-native pharmaceutical company focused on accelerating drug development and bringing new treatments to patients faster and more efficiently. They leverage a proprietary AI-native platform to improve efficiency across the drug development lifecycle, from drug selection to clinical trials. The company acquires clinical-stage assets and applies its technology and expertise to advance them through key value inflection points, aiming to realize greater value per program and provide earlier access to treatments. Their multidisciplinary team comprises experts in drug selection, drug development, and technology, with a collective experience in over 45 approved drugs. Formation Bio targets critical unmet patient needs across various therapeutic areas, addressing the bottleneck in drug development where costs have increased exponentially despite scientific advancements.

Formation Bio is a tech-driven, AI-native pharmaceutical company focused on accelerating drug development and bringing new treatments to patients faster and more efficiently. They leverage a proprietary AI-native platform to improve efficiency across the drug development lifecycle, from drug selection to clinical trials. The company acquires clinical-stage assets and applies its technology and expertise to advance them through key value inflection points, aiming to realize greater value per program and provide earlier access to treatments. Their multidisciplinary team comprises experts in drug selection, drug development, and technology, with a collective experience in over 45 approved drugs. Formation Bio targets critical unmet patient needs across various therapeutic areas, addressing the bottleneck in drug development where costs have increased exponentially despite scientific advancements.
About Formation Bio Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development. Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others.
You Can Read More At The Following Links
At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently.
About The Position As Vice President of Trial Engine, you are the accountable leader for how Formation Bio executes clinical trials across our portfolio. This role builds on an existing, differentiated trial execution and data platform, and is accountable for scaling and strengthening it as the portfolio grows. That means running and continuously improving a trial execution engine that delivers speed, cost efficiency, and quality predictably. You will optimize planning and execution across our trials and drive iteration and improvement across every part of our delivery approach.
We’re not looking for a traditional Clinical Operations leader. This is an outcomes oriented, first principled, velocity-obsessed, player + coach + builder role for someone who knows clinical trials can and must be run faster, cheaper, and better at the same time. You will lead multiple functions, serve as a trial team leader yourself, and work in close partnership with the Development, Translational, Technology, Business Operations & Strategy and Quality teams to continue to build capabilities, including AI enabled, that ensure we deliver new treatments to patients faster and more efficiently. If you want a steady-state org, inherited process, and the ability to rely solely on your experience, you’re not the right person.
Responsibilities Own and Drive Trial Outcomes
Lead Multiple Trial Engine Enablement Teams
Lead and develop leaders across:
Clinical Trial Management & Operations (Trial Management, Project Management, Trial Master File)
Site Feasibility & Operations (Feasibility, Study Startup, Recruitment)
Clinical Data Management & Analytics
Generate operational alpha through the pace you set, the systems and technology you deploy and the people you develop and hire.
Build high-performing teams that scale impact without corresponding headcount
Evolve the Trial Delivery Operating Model
Partner Cross-Functionally With
About You
Signals That You Are a Good Fit
Formation Bio is prioritizing hiring in key hubs, primarily the New York City and Boston metro areas. These positions will follow a hybrid work model with 1-3 days required at the office. Applicants from the Research Triangle (NC) and San Francisco Bay Area may also be considered. Please only apply if you reside in these locations or are willing to relocate. Compensation The target salary range for this role is: $333,000 - $370,000 Salary ranges are informed by a number of factors including geographic location. The range provided includes base salary only. In addition to base salary, we offer equity, comprehensive benefits, generous perks, hybrid flexibility, and more. If this range doesn't match your expectations, please still apply because we may have something else for you.
You will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.